Европейски съюз -
български -
EMA (European Medicines Agency)
rybrevant
janssen-cilag international n.v. - amivantamab - Карцином, недребноклетъчен белодроб - Антинеопластични средства - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.
Европейски съюз -
български -
EMA (European Medicines Agency)
tepmetko
merck europe b.v. - tepotinib hydrochloride monohydrate - Карцином, недребноклетъчен белодроб - Антинеопластични средства - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.
България -
български -
БАБХ (Българска агенция по безопасност на храните)
eprifarm 5,00 mg/ml
Фарма Вет ООД - eprinomectin - разтвор за поливане - 5,00 mg/ml - говеда
